WNBA Drops Marijuana from Banned Substances List in Historic Shift

League Policy Takes Effect Immediately

The WNBA's new cannabis policy eliminates all testing and penalties for marijuana use, effective with the start of the 2026 season. Players won't face fines, suspensions, or mandatory treatment programs for cannabis use, whether medical or recreational. The change applies to both in-season and off-season conduct.

Negotiators hammered out the policy revision during the league's 2026 collective bargaining agreement talks. WNBA Players Association executive director Terri Jackson confirmed the update in a statement Thursday, calling it "a recognition of evolving science and state laws."

Why This Matters for Professional Sports

The WNBA's move pressures other leagues to reconsider cannabis policies as 38 states have legalized medical marijuana and 24 allow adult use. The NBA suspended random marijuana testing during the pandemic but hasn't formalized a permanent ban removal. The NFL reduced penalties but still tests. MLB removed it from the banned list in 2019 but maintains treatment protocols.

Players across leagues have pushed for reform, citing pain management needs and the gap between federal prohibition and state-level legalization. The WNBA's full elimination sets a new baseline.

Player Advocacy Drove the Change

WNBA players have been vocal about cannabis as a recovery tool, particularly for joint inflammation and sleep disruption from travel schedules. Sue Bird, who retired in 2022, publicly advocated for policy reform during her final seasons. Current players echoed the call during CBA negotiations. They pointed to the physical toll of a compressed schedule and limited recovery windows.

The league plays a 40-game regular season from May through September, with minimal off days between road trips. Many players describe cannabis as preferable to opioids for managing chronic pain from repetitive stress injuries.

The Business Angle: Sponsorship and Endorsements

Removing the ban opens endorsement opportunities for WNBA players in the legal cannabis market, estimated at $33 billion in U.S. sales for 2026. Athletes in non-prohibited sports have signed deals with CBD brands, cannabis wellness companies, and state-licensed operators. The WNBA's policy clears the path for similar partnerships without league conflict.

Several players have already invested in cannabis startups or launched CBD lines. Now they can promote those ventures publicly. No risk of league discipline.

For more on how cannabis policy intersects with professional athletics, see the CannIntel topic hub on Cannabis and Professional Sports.

What Other Leagues Are Watching

The WNBA's precedent could accelerate reform in the NBA, where players and the union have lobbied for full removal since 2020. The NBA's current policy suspends random testing but retains marijuana on the banned list for "reasonable cause" testing. Commissioner Adam Silver has signaled openness to change but hasn't committed to a timeline.

NFL policy remains the most restrictive among major leagues, with positive tests triggering mandatory evaluations. The league raised the THC threshold in 2020 but hasn't moved toward full elimination. The WNBA's shift adds pressure as younger players enter the league from states where cannabis is normalized.

We'll be watching whether the NBA follows suit during its next CBA cycle in 2029.